自己免疫疾患用薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Autoimmune Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings
• Assumptions

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Disease overview
• Understanding the disease
• Etiology
• Signs and symptoms
• Diagnosis
• Management
• Economic burden
• Epidemiology

PART 06: Pipeline portfolio

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by type of disease
• RA
• MS
• PsA
• IBD
• AS
• SLE
• Global RA drugs market
• Clinical trials for RA
• Global MS drugs market
• Global PsA drugs market
• Global IBD drugs market
• Global AS drugs market
• Global SLE drugs market

PART 09: Market segmentation by mechanism of action
• TNF inhibitors
• IL-1 blockers
• COX inhibitors
• PDE4 inhibitors
• Others

PART 10: Market segmentation by drug class
• DMARDs
• NSAIDs
• Corticosteroids
• Analgesics
• Immunosuppressants
• Others

PART 11: Market segmentation by type of molecule
• Biologics
• Small molecules

PART 12: Market segmentation by ROA
• Oral
• Parenteral
• Topical

PART 13: Market segmentation by dosage form
• Solid
• Liquid
• Semi-solid

PART 14: Geographical segmentation
• Autoimmune diseases drugs market in the Americas
• Autoimmune diseases drugs market in US
• Autoimmune diseases drugs market in EMEA
• Autoimmune diseases drugs market in APAC
• Autoimmune diseases drugs market in Japan
• Autoimmune diseases drugs market in China

PART 15: Market drivers
• Rising prevalence of autoimmune diseases
• Growing older population
• Dominance of biologics
• Unmet medical needs
• Promising pipeline

PART 16: Impact of drivers

PART 17: Market challenges
• Increasing cost of biologics
• Loss of patent exclusivity of branded therapies
• Complex nature of autoimmune diseases
• Preference for CAMs
• Adverse effects

PART 18: Impact of drivers and challenges

PART 19: Market trends
• Emergence of biosimilars
• Patient assistance programs
• Increase in public awareness programs
• Strategic alliances
• Popularity of off-label and traditional treatment options

PART 20: Vendor landscape
• Competitive scenario
• Market analysis 2015
• AbbVie
• Johnson & Johnson
• Biogen
• Amgen
• Pfizer
• F. Hoffmann-La Roche
• Other prominent vendors

PART 21: Appendix
• List of abbreviations

PART 22: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Etiology of autoimmune diseases
Exhibit 03: Signs and symptoms of autoimmune diseases
Exhibit 04: Diagnostic methods for autoimmune diseases
Exhibit 05: Non-pharmacological therapies used for autoimmune diseases
Exhibit 06: Pharmacotherapy therapies used for autoimmune diseases
Exhibit 07: Top drugs for autoimmune diseases
Exhibit 08: Average annual treatment costs of RA in US and Europe 2014 ($ billions)
Exhibit 09: Average annual treatment costs of MS across countries 2014 ($ billions)
Exhibit 10: Average annual treatment costs of PsA across countries 2014 ($ billions)
Exhibit 11: Prevalence and incidence of SLE
Exhibit 12: Pipeline molecules for RA
Exhibit 13: Pipeline molecules for MS
Exhibit 14: Pipeline molecules for PsA
Exhibit 15: Pipeline molecules for CD
Exhibit 16: Pipeline molecules for UC
Exhibit 17: Pipeline molecules for SLE
Exhibit 18: Global autoimmune diseases drugs market 2015-2020 ($ billions)
Exhibit 19: Five forces analysis
Exhibit 20: Global autoimmune diseases drugs market segmentation by type of disease
Exhibit 21: Global autoimmune diseases drugs market by type of disease 2015
Exhibit 22: Global autoimmune diseases drugs market: YoY revenue and growth based on autoimmune diseases 2015-2020
Exhibit 23: Global RA drugs market 2015-2020 ($ billions)
Exhibit 24: Global RA drugs market by drug class 2015
Exhibit 25: Top-vendor offerings for global RA drugs market
Exhibit 26: RA clinical trial by Phase 2015
Exhibit 27: RA clinical trial by status 2015
Exhibit 28: Drivers and challenges of global RA drugs market
Exhibit 29: Global MS drugs market 2015-2020 ($ billions)
Exhibit 30: Global MS drugs market by molecule type 2015
Exhibit 31: Top-vendor offerings for global MS drugs market
Exhibit 32: Drivers and challenges of global MS drugs market
Exhibit 33: Global PsA drugs market 2015-2020 ($ billions)
Exhibit 34: Global PsA drugs market segmentation by MOA 2015
Exhibit 35: Top-vendor offerings for global PsA drugs market
Exhibit 36: Drivers and challenges of global PsA drugs market
Exhibit 37: Global IBD drugs market 2015-2020 ($ billions)
Exhibit 38: Global IBD drugs market by type of disease 2015
Exhibit 39: Global IBD drugs market by drug class 2015
Exhibit 40: Top-vendor offerings for global IBD drugs market
Exhibit 41: Drivers and challenges of global IBD drugs market
Exhibit 42: Global AS drugs market 2015-2020 ($ billions)
Exhibit 43: Global AS drugs market by MOA 2015
Exhibit 44: Top-vendor offerings for global AS drugs market
Exhibit 45: Drivers and challenges of global AS drugs market
Exhibit 46: Global SLE drugs market 2015-2020 ($ billions)
Exhibit 47: Drivers and challenges of global SLE drugs market
Exhibit 48: Global autoimmune diseases drugs market segmentation by MOA
Exhibit 49: Average percentage of patients receiving TNF inhibitors 2010 and 2015
Exhibit 50: Global autoimmune diseases drugs market share by MOA 2015
Exhibit 51: Global autoimmune diseases drugs market segmentation by drug class
Exhibit 52: Examples of non-biologic DMARDs and biologic DMARDs for autoimmune diseases
Exhibit 53: NSAIDs used to treat autoimmune diseases
Exhibit 54: Global autoimmune diseases drugs market by drug class 2015
Exhibit 55: Global autoimmune diseases drugs market segmentation by type of molecule
Exhibit 56: Global autoimmune diseases biologics market 2015-2020 ($ billions)
Exhibit 57: Global autoimmune diseases small molecules market 2015-2020 ($ billions)
Exhibit 58: Global autoimmune diseases drugs market by type of molecules 2015
Exhibit 59: Global autoimmune diseases drugs market segmentation by ROA
Exhibit 60: Global autoimmune diseases drugs market segmentation by ROA 2015
Exhibit 61: Global autoimmune diseases drugs market segmentation by dosage form
Exhibit 62: Global autoimmune disease drugs market segmentation by dosage form 2015
Exhibit 63: Global autoimmune diseases drugs market segmentation by geography 2015
Exhibit 64: Global autoimmune diseases drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 65: Autoimmune diseases drugs market in the Americas 2015-2020 ($ billions)
Exhibit 66: Autoimmune diseases drugs market in America by country 2015
Exhibit 67: Autoimmune diseases drugs market in US 2015-2020 ($ billions)
Exhibit 68: Drivers and challenges for autoimmune diseases drugs market in the US
Exhibit 69: Autoimmune diseases drugs market in EMEA 2015-2020 ($ billions)
Exhibit 70: Autoimmune diseases drugs market in APAC 2015-2020 ($ billions)
Exhibit 71: Autoimmune diseases drugs market in Japan 2015-2020 ($ billions)
Exhibit 72: Drivers and challenges for autoimmune diseases drugs market in Japan
Exhibit 73: Autoimmune diseases drugs market in China 2015-2020 ($ billions)
Exhibit 74: Global autoimmune diseases drugs market YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 75: Population aged 60 years and over ($ millions)
Exhibit 76: Biologics approval timeline by US FDA
Exhibit 77: Some pipeline molecules under phases of development for autoimmune diseases
Exhibit 78: Impact of drivers
Exhibit 79: Average annual treatment cost of adalimumab, etanercept, and infliximab 2014 ($ millions)
Exhibit 80: Approval and patent expiries of top selling biologics
Exhibit 81: CAM therapies for autoimmune diseases
Exhibit 82: Usage of CAM therapies among individuals in US 2014
Exhibit 83: Adverse effects associated with autoimmune disease therapies
Exhibit 84: Impact of drivers and challenges
Exhibit 85: Patient assistance programs for autoimmune diseases drugs
Exhibit 86: Revenue share of major companies for autoimmune diseases 2015
Exhibit 87: YoY Sales comparison of top drugs 2013-2015 ($ billions)
Exhibit 88: AbbVie: Product segmentation by revenue 20150
Exhibit 89: AbbVie: YoY growth rate and revenue of HUMIRA 2013-2015 ($ billions)
Exhibit 90: AbbVie: YoY growth rate and revenue of HUMIRA in US 2013-2015 ($ billions)
Exhibit 91: AbbVie: YoY growth rate and revenue of HUMIRA in ROW 2013-2015 ($ billions)
Exhibit 92: Sales of HUMIRA in major markets
Exhibit 93: AbbVie: Key takeaways
Exhibit 94: Johnson & Johnson: Segmentation of key autoimmune diseases drugs 2014
Exhibit 95: Johnson & Johnson: YoY growth rate and revenue of Remicade 2013-2014 ($ billions)
Exhibit 96: Johnson & Johnson: YoY growth rate and revenue of Remicade in US 2013-2015 ($ billions)
Exhibit 97: Johnson & Johnson: YoY growth rate and revenue of Remicade in ROW 2013-2015 ($ billions)
Exhibit 98: Johnson & Johnson: YoY growth rate and revenue of Stelara 2013-2015 ($ billions)
Exhibit 99: Johnson & Johnson: YoY growth rate and revenue of Stelara in US 2013-2015 ($ billions)
Exhibit 100: Johnson & Johnson: YoY growth rate and revenue of Stelara in ROW 2013-2015 ($ millions)
Exhibit 101: Johnson & Johnson: YoY growth rate and revenue of Simponi/Simponi Aria 2013-2015 ($ billions)
Exhibit 102: Johnson & Johnson: YoY growth rate and revenue of Simponi/Simponi Aria in US 2013-2015 ($ millions)
Exhibit 103: Johnson & Johnson: YoY growth rate and revenue of Simponi/Simponi Aria in ROW 2013-2015 ($ millions)
Exhibit 104: Johnson & Johnson: Key takeaways
Exhibit 105: Biogen: Product segmentation of key autoimmune diseases drugs by revenue 2015
Exhibit 106: Top selling autoimmune diseases drugs
Exhibit 107: Biogen: YoY growth rate and revenue of Tecfidera 2013-2015 ($ billions)
Exhibit 108: Biogen: YoY growth rate and revenue of Avonex 2013-2015 ($ billions)
Exhibit 109: Biogen: YoY growth rate and revenue of Tysabri 2013-2015 ($ billions)
Exhibit 110: Biogen: YoY revenue of Plegridy 2014-2015 ($ millions)
Exhibit 111: Biogen: YoY growth rate and revenue of Fampyra 2013-2015 ($ millions)
Exhibit 112: Biogen: Key takeaways
Exhibit 113: Amgen: YoY growth rate and revenue of Enbrel in US and Canada 2013-2015 ($ billions)
Exhibit 114: Amgen: YoY growth rate and revenue of Enbrel in US 2013-2015 ($ billions)
Exhibit 115: Amgen: YoY growth rate and revenue of Enbrel in Canada 2013-2015 ($ millions)
Exhibit 116: Amgen: Key takeaways
Exhibit 117: Pfizer: Autoimmune diseases drugs product segmentation by revenue 2014
Exhibit 118: Top selling autoimmune diseases drugs
Exhibit 119: Pfizer: YoY growth rate and revenue of Enbrel (outside US and Canada) 2013-2015 ($ billions)
Exhibit 120: Pfizer: YoY growth rate and revenue of Celebrex 2013-2015 ($ billions)
Exhibit 121: Pfizer: YoY growth rate and revenue of Xeljanz 2012-2014 ($ millions)
Exhibit 122: Pfizer: Key takeaways
Exhibit 123: Top selling autoimmune diseases drugs
Exhibit 124: F. Hoffmann-La Roche: YoY growth rate and revenue of Actemra/RoActemra 2013-2015 ($ billions)
Exhibit 125: F. Hoffmann-La Roche: Actemra/RoActemra geographic segmentation by revenue 20155
Exhibit 126: F. Hoffmann-La Roche: YoY growth rate and revenue of MabThera/Rituxan (oncology and immunology indications) 2013-2015 ($ billions)
Exhibit 127: F. Hoffmann-La Roche: YoY growth rate and revenue of MabThera/Rituxan (immunology indications only) 2013-2015 ($ billions)
Exhibit 128: F. Hoffmann-La Roche: Geographic segmentation of MabThera/Rituxan by revenue 2015
Exhibit 129: F. Hoffmann-La Roche: Key takeaways


【レポート販売概要】

■ タイトル:自己免疫疾患用薬の世界市場2016-2020
■ 英文:Global Autoimmune Drugs Market 2016-2020
■ 発行日:2016年3月18日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9055
■ 調査対象地域:グローバル
  • 不妊治療の世界市場予測(~2022年):生殖補助技術(ART)、人工授精、IVF、代理母出産、不妊手術
    The global infertility treatment devices market is expected to reach USD 2.05 Billion by 2022 from USD 1.24 Billion in 2017, at a CAGR of 10.6% from 2017 to 2022. The rising public awareness about various treatment options is an important growth driver for this market. However, the high procedural costs and unsupportive government regulations are the major factors restraining the growth of this ma …
  • スペインの血液バンク市場2014
    This report provides an overview of the Spanish blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well as test volume and sales forecasts by market segment.Table of ContentsBusiness Environment  Market StructureMarket Size, Growth and Major Suppliers’ Sales and Market Shares   & …
  • 量子暗号の世界市場予測(~2023年)
    Global quantum cryptography market size to grow at a CAGR of 37.9% during the forecast periodThe global quantum cryptography market is expected to grow from USD 101 million in 2018 to USD 506 million by 2023, at a Compound Annual Growth Rate (CAGR) of 37.9% during the forecast period. Major growth factors for the market include the growing incidents of cyber-attacks in the era of digitalization, i …
  • 紙・板紙容器および包装の世界市場2016-2020
    About Paper and Paperboard Containers and Packaging Paper and paperboard packaging is gaining importance in many countries and is an emerging trend in the packaging industry because of its various advantages such as its environmentally friendly and cost-effective nature. Paperboard is thicker, with a high weight per unit area, and is made in multiple layers. The containers are generally made of vi …
  • 4G Handsets: Evaluating the Impact of LTE, Applications, and Anticipated Usage
    The Long Term Evolution (LTE) standard was introduced in 3GPP (3rd Generation Partnership Project) Release 8 as an evolutionary step representing the fourth generation (4G) of cellular communications. It provides an enhanced user experience for broadband wireless networks and will usher in a plethora of new bandwidth dependent applications. This research analyzes current mobile handsets market as …
  • ペットフード加工の世界市場予測(~2022年):加工装置(混合装置、成形機械、ベーキング装置、乾燥装置)、動物(犬、猫、その他)
    The global pet food processing market, by equipment, has grown considerably in the last few years. The market size of pet food processing equipment is projected to reach USD 4.27 Billion by 2022, at a CAGR of around 3.5% from 2016. Pet food manufacturers demand new and automated pet food processing machineries in order to ensure an uninterrupted production flow. Increasing usage of processed & pac …
  • 世界のHot Drinks市場におけるニュース・イベント動向(2014年2月)
    Synopsis The report provides a review of the latest news and key events in the global hot drinks market during February 2014. Summary Using this report, marketers will effectively gain an insight into the latest happenings in the global hot drinks market throughout the month. The monthly report provides the reader with the top-line data necessary to quickly keep abreast of latest events in the glo …
  • 地上型3次元レーザースキャナ(TLS)の世界市場2015-2019
    About 3D terrestrial laser scanning Scanners are measuring instruments based on lasers. Terrestrial laser scanning is a new and efficient method of digitization data related to large objects for surveys. It enables capturing of complex geometric data from buildings, objects, and machines. Laser scanners are used for topographical surveys to provide deliverables such as spatial cloud data, DEM, DTM …
  • 世界の酸性調節装置市場
    Food acidulants form an integral part of the global food additives industry as these provide an acidic medium and flavor to food and beverage items. These regulate the acidity of the food and help to increase shelf life. These also prevent the microbial activity and play a major role in food preservation. This research report provides a comprehensive analysis of the global food acidulants market, …
  • 世界のモバイル音楽アクセサリー市場動向(2012-2016)
    TechNavio's analysts forecast the Global Mobile Music Accessories market to grow at a CAGR of 12.55 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing number of technological advancement and innovations. The Global Mobile Music Accessories market has also been witnessing partnerships between mobile device manufacturers and music accessori …
  • Devon Energy Corporation:石油・ガスバリューチェーン分析レポート2013
    Devon Energy Corporation Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Devon Energy Corporation" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Devon Energy Corporation”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The …
  • International-Matex Tank Terminals:石油・ガスバリューチェーン分析レポート2013
    International-Matex Tank Terminals Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "International-Matex Tank Terminals" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “International-Matex Tank Terminals”. The report provides key information relating to oil and gas assets of the company along with its operatio …
  • ナトリウム低減成分の世界市場2016-2026
    The latest report from business intelligence provider visiongain offers new analysis of the global Sodium Reduction Ingredients market. Visiongain assesses that this market will generate revenues of $791.5m in 2016. Now: ” Salt of the Earth Targets Sodium Reduction in the UK”, “Despite federal strategy, researchers see minimal change to Canadians' sodium intake” These are examples of the business …
  • Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019
    Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019 Summary GlobalData, the industry analysis specialist, has released its new report, “Amyotrophic Lateral Sclerosis – Analysis and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Amyotrophic Lateral Sclerosis Therapeutics market. The report identifies the key trends shaping an …
  • 圧力スイッチの世界市場:タイプ別(電気機械式、ソリッドステート)、圧力範囲別(100バール未満、100〜400バール、400バール超)、用途別(HVAC、監視・制御、安全・警報システム、油圧・空気圧)、エンドユーザー別(自動車・輸送、プロセス・製造業、商業)、地域別予測
    Pressure Switch Market to reach USD 2.11 billion by 2025. Pressure Switch Market valued approximately USD 1.44 billion in 2016 is anticipated to grow with a healthy growth rate of more than 4.35% over the forecast period 2017-2025. Pressure switches market is expected to exhibit a slow growth during the forecast period. However, it is likely to have revenue pockets from markets in Asia, the Middle …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。